featured
Safety of Treatment With Anti–IL-4/IL-13 Agents vs JAK Inhibitors in Patients With Atopic Dermatitis
Sign in to PracticeUpdate
Only registered members have full access to PracticeUpdate content.
Additional Info
Journal of the American Academy of Dermatology
From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.
Comparative Safety Analysis of Anti-IL-4/IL-13 Inhibitors and JAK Inhibitors in Atopic Dermatitis
J Am Acad Dermatol 2024 Jul 04;[EPub Ahead of Print], A Bao, HJ Su, J WanFrom MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.